Dictionary

allow_url_fopen is ENABLED Dictionary Search

tardive

Synonyms

Adjective

1. late

Usage
Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of INGREZZA® (valbenazine) Capsules Across a Broad Range of Patients - PR Newswire
Teva Pharmaceuticals Reports Positive New Data on AUSTEDO and AUSTEDO XR for Tardive Dyskinesia Management at Psych Congress Elevate - Quiver Quantitative
Neurocrine presents tardive dyskinesia treatment data at conference - StreetInsider
Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care - Yahoo! Finance Canada
Teva (TEVA) Reports Positive Outcomes for Tardive Dyskinesia Tre - GuruFocus
Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities - PR Newswire
Living with Tardive Dyskinesia - Brain & Life
Neurocrine presents data on tardive dyskinesia treatment By Investing.com - Investing.com Canada
Patients With Tardive Dyskinesia Symptoms May Go Undiagnosed - MedPage Today
Spotlight on the Psychosocial Impact of Tardive Dyskinesia - Psychiatry Advisor
Measuring What Matters: Further Validation for the Tardive Dyskinesia Impact Scale, a Novel Patient-Reported Outcome Measure in Valbenazine Clinical Trials - Psychiatrist.com
CMS Moves to Close the Tardive Dyskinesia Screening Gap - Pharmacy Practice News
Risk of Tardive Dyskinesia Higher in Women - MedPage Today
Diagnostic Challenges in Distinguishing Huntington Disease From Tardive Dyskinesia - Psychiatrist.com
'Mild' TD still affects daily life; new data track treatment gains - Stock Titan
Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment - PR Newswire
Tardive Dyskinesia: 11 Tips to Feel More in Control of Uncontrollable Movements - Everyday Health
Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules - PR Newswire
Neurocrine reports positive INGREZZA data for TD in patients with IDD - grafa.com
Tardive Dyskinesia in Older Adults: Identification and Management in Long-Term Care Settings - Psychiatric Times
Tardive Dyskinesia in Children and Adolescents: Uncommon, but Not Absent - Pharmacy Practice News
The Patient Perspective on Tardive Dyskinesia - Psychiatrist.com
First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings - Psychiatric Times
AI Screening Tool for Tardive Dyskinesia Identifies Disorder and Prompts Clinical Evaluation - Psychiatric Times
New Data From IMPACT-TD Registry: Only 23% of Young Adults With Mood Disorders and Tardive Dyskinesia Symptoms Are Formally Diagnosed - Psychiatric Times
First Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings - Pharmacy Practice News
A Look At Teva (TEVA) Valuation After New Real World Tardive Dyskinesia Data Release - Yahoo Finance
Masking and Unmasking in Tardive Dyskinesia - Pharmacy Practice News
Dental Complications Tardive Dyskinesia Care Insights - Pharmacy Practice News
Tardive Dyskinesia Treatment - Everyday Health
Building a Tardive Dyskinesia Center of Excellence: A Multidisciplinary Model - Pharmacy Practice News
Why Mild Tardive Dyskinesia Is Often the Hardest To Manage - Pharmacy Practice News
Caregiving Guide for Helping to Manage Tardive Dyskinesia - HealthCentral
VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia - NeurologyLive
Coping with Tardive Dyskinesia Stigma: An Advocate's Perspective - Healthline
The Polypharmacy Challenge in Tardive Dyskinesia - Pharmacy Practice News
Senator McKnight Highlights the Importance of Tardive Dyskinesia Awareness Week - New Jersey Senate Democrats
Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders - Pharmacy Practice News
Risk Factors of Tardive Dyskinesia - Pharmacy Times
Pharmacists Can Drive Improved Tardive Dyskinesia Screening and Care, Real-World Data Suggest - Pharmacy Practice News
Seen but Unseen: Tardive Dyskinesia in Long-Term Care - Pharmacy Practice News
Phase 2 Study Initiated for NBI-1065890 to Treat Tardive Dyskinesia - Psychiatric Times
New Review on VMAT2 Inhibitors and Ingrezza for Treatment of Tardive Dyskinesia - Psychiatric Times
Tardive Dyskinesia Burden Perspectives from Physicians and Patients - Pharmacy Practice News
How VMAT2 Inhibitors Are Reshaping Tardive Dyskinesia Care - Pharmacy Practice News
Assessing Tardive Dyskinesia: AIMS and the Clinician’s Tardive Inventory - Pharmacy Practice News
Navigating Treatment for Huntington's Disease (Part 7) - Pharmacy Practice News
Medicare Policy Expansion: Implications for Patients With Tardive Dyskinesia - Clinical Advisor
Pharmacists Can Help Close The Tardive Dyskinesia Dx Gap - Pharmacy Practice News
6 Ways to Cope With Tardive Dyskinesia Stigma - Everyday Health
Most Tardive Dyskinesia Cases Go Undiagnosed, Real-World Study Finds - Pharmacy Practice News
Why the Daily Burden of Tardive Dyskinesia Is Still So Often Misunderstood - Pharmacy Practice News
Teva Pharmaceuticals Highlights Diagnostic Gaps in Tardive Dyskinesia Impacting Patients with Mood Disorders, According to New IMPACT-TD Registry Analysis - Quiver Quantitative
Accurate Diagnosis of Tardive Dyskinesia Is Critical to Optimal Outcomes - Pharmacy Practice News
EMA Says Active Substance in Tardive Dyskinesia Drug Not New - Medscape
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia - PR Newswire
Tardive Dyskinesia's Impact on Quality of Life - MedPage Today
Decreased N-acetylaspartate plus N-acetyl-aspartyl-glutamate levels in the caudate of schizophrenia patients with tardive dyskinesia - Nature
Valbenazine Linked to Better Physical and Emotional Well-Being in Tardive Dyskinesia - NeurologyLive
AI Eyes on TD: Could Video-Based Detection Shrink the Diagnosis Gap? - Pharmacy Practice News
New data support early use of Ingrezza in mild tardive dyskinesia - The Pharma Letter
Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact - Yahoo Finance
Phase 4 Data Support Effectiveness of Deutetrabenazine in Managing Tardive Dyskinesia, Chorea - NeurologyLive
VMAT2 Inhibitor Tardive Dyskinesia Treatment Complexity - Pharmacy Practice News
Teva reports diagnostic gap in tardive dyskinesia patients - Investing.com
This condition affects at least 5% of people who take antipsychotic medication - Health: Trusted and Empathetic Health and Wellness Information
Neuroleptic Malignant Syndrome Unmasked: A Case of Extrapyramidal Syndrome With Tardive Dystonia Leading to a Life-Threatening Crisis - Cureus
Real-world data shows AUSTEDO improves life for patients with tardive dyskinesia - PharmaTimes
Neurocrine cites work disruption data to make case for timely movement disorder diagnosis - Fierce Pharma
Mitigating the Risk For Tardive Dyskinesia in Elderly Patients on Antipsychotics - MedPage Today
Patient Awareness of Tardive Dyskinesia: Insights From Cherian Karunapuzha, MD - Psychiatric Times
Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden - PR Newswire
Tardive Dyskinesia Management Gaps in LongTerm Care - Pharmacy Practice News
9 Questions to Ask Your Doctor About Taking VMAT2 Inhibitors for TD - HealthCentral
Acute exacerbation of major depressive disorder following valbenazine treatment for tardive dyskinesia: A case report - Wiley Online Library
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR - PR Newswire
Assessing Neurocrine Biosciences (NBIX) Valuation After New Phase 2 VMAT2 Tardive Dyskinesia Trial Launch - Yahoo Finance
Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis - Yahoo Finance
Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive - Fierce Pharma
Digital Tools to Detect Tardive Dyskinesia - MedPage Today
VIDEO: Using the ‘gold standard’ assessment for tardive dyskinesia diagnosis - Healio
Clinical practice guidelines for the treatment of tardive dyskinesia in Europe: A descriptive review - Cambridge University Press & Assessment
Deep Brain Stimulation for Tardive Dyskinesia - MedPage Today
Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice - Pharmacy Times
What’s New in Tardive Dyskinesia, With Jonathan Meyer, MD - HCPLive
Assessing Teva (NYSE:TEVA) Valuation After New IMPACT-TD Registry Findings On Tardive Dyskinesia - Sahm
Tardive Dyskinesia: When the Meds That Help Start to Hurt - Texas Metro News
Survey: 'mild' movement disorder disrupts life, most improve on INGREZZA - Stock Titan
Neurocrine Biosciences begins Phase II NBI-1065890 trial for TD - Clinical Trials Arena
Well-Rounded Examination for Treatment of Tardive Dyskinesia - Psychiatric Times
Assessing Teva (NYSE:TEVA) Valuation After New IMPACT-TD Registry Findings On Tardive Dyskinesia - simplywall.st
Teva study exposes major diagnosis gap in Tardive Dyskinesia - Indian Pharma Post
Survey: adults with tardive dyskinesia missed 8 work hours a week - Stock Titan
When Movement Isn’t the Primary Problem: Reframing Treatment Priorities in Early Huntington’s Disease - Pharmacy Practice News
Young adults endure TD symptoms for years without a diagnosis, Teva finds - Stock Titan
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR - PR Newswire
VIDEO: Tardive dyskinesia can ‘pretty significantly’ impact patients’ quality of life - Healio
Grammy award winning singer-songwriter raising awareness about Tardive Dyskinesia - WTVM.com
Teva Taps Terrell (TD) Davis To Combat 'The Other TD' (Tardive Dyskinesia) 11/11/2025 - MediaPost
VIDEO: Available treatment options in tardive dyskinesia - Healio
Foreign Language Equivalents
Foreign Language Equivalents of 'tardive'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
tarduve,   tarsive,   taardive,   tadrive,   tsrdive,   tardie,   tardivee,   tardibe,   taedive,   tradive,   tatdive,   tadive,   tarive,   yardive,   tardivr,   tardice,   tardve,   tardove,   rardive,   tardivw,   tarfive,   taridve,   tarddive,   trdive,   tardivve,   tardiev,   ardive,   ttardive,   tardiv,   tardvie,   tarrdive,   tardiive,   atrdive
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z